| Financial Year |
March 31 2023 |
| Monetary Funds |
83,507,809.83 |
| Held-for-trading Financial Assets |
144,275,330.10 |
| Notes Receivable |
1,007,640.00 |
| Accounts Receivable |
321,211,101.83 |
| Advances to Suppliers |
9,127,778.50 |
| Other Receivables |
13,691,621.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
208,673,602.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,079,626.50 |
| Total Current Assets |
796,359,733.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
197,509,508.99 |
| Fixed Assetes |
1,722,877,765.68 |
| Under-construction Projects |
160,589,537.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
257,315,261.43 |
| R&D expenses |
243,290,149.63 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,339,594.58 |
| Deferred Income Tax Assets |
39,895,508.64 |
| Other Non-Current Assets |
122,361,740.92 |
| Sub-Total of Non-Current Assets |
2,785,318,542.18 |
| Total Assets |
3,581,678,275.24 |
| Short-Term Loans |
353,271,935.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
127,738,543.11 |
| Accounts Received In Advance |
3,413,953.67 |
| Employee Compensation Payable |
19,565,589.44 |
| Taxes Payable |
9,128,793.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,049,044.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
631,767,405.56 |
| Other Current Liabilities |
6,628,783.86 |
| Sub-Total of Current Liabilities |
1,282,186,413.71 |
| Long-term Loans |
830,169,491.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
17,059,830.51 |
| Deferred Income Tax Liabilities |
4,201,121.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
973,331,387.59 |
| Total Liabilities |
2,255,517,801.30 |
| Paid-In Capital(Or Share Stock) |
883,241,336.00 |
| Capital Surplus |
1,475,395,565.09 |
| Surplus Reserve |
56,688,751.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,151,397,416.30 |
| Minority Stockholder's Interest |
25,964,700.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,300,195,773.92 |
| Owner's Equity（Stockholder's Equity） |
1,326,160,473.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,581,678,275.24 |
